13M166: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Omics (1693–1698)

Presenting Author(s)

• PC

  Philip Carlucci, MD

  New York University School of Medicine
  New York, NY, United States

  Disclosure information not submitted.
• 

  Huihua Ding, MD

  Shanghai Jiao Tong University School of Medicine affiliated Renji Hospital
  Shanghai, Shanghai, China

  Disclosure information not submitted.
• SH

  Sarfaraz Hasni, MD, MSc

  National Institutes of Health
  Bethesda, MD, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• AH

  Alice Horisberger, MD

  Brigham and Woman's Hospital, Harvard medical school
  Boston, MA, United States

  Disclosure information not submitted.
• PL

  Peter Lipsky, MD

  AMPEL BioSolutions
  Charlottesville, VA, United States

  Disclosure information not submitted.
• 

  Ioannis Parodis, MD, PhD

  Karolinska Institutet
  Stockholm, Sweden

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 4:00 PM – 4:10 PM PT

  Blood Immunophenotyping Distinguishes Three Subgroups of Lupus Nephritis Patients with Distinct Kidney Infiltrates and Interferon Signatures
  

  Presenting Author: Alice Horisberger, MD – Brigham and Woman's Hospital, Harvard medical school
• 4:10 PM – 4:15 PM PT

  Q&A
  
• 4:15 PM – 4:25 PM PT

  Transcriptomic Analysis of the Impact of Iberdomide on Patients with SLE
  

  Presenting Author: Peter Lipsky, MD – AMPEL BioSolutions
• 4:25 PM – 4:30 PM PT

  Q&A
  
• 4:30 PM – 4:40 PM PT

  Single Cell Transcriptomics in Kidney Tissue from African American Patients Enrolled in the Accelerating Medicines Partnership (AMP) Implicates Tubular Cells in the Pathogenesis of APOL1 Associated Lupus Nephritis
  

  Presenting Author: Philip Carlucci, MD – New York University School of Medicine
• 4:40 PM – 4:45 PM PT

  Q&A
  
• 4:45 PM – 4:55 PM PT

  Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Systemic Lupus Erythematosus Prognosis
  

  Presenting Author: Sarfaraz Hasni, MD, MSc – National Institutes of Health
• 4:55 PM – 5:00 PM PT

  Q&A
  
• 5:00 PM – 5:10 PM PT

  Molecular Characterisation of Remission and Lupus Low Disease Activity State (LLDAS) by Whole-Blood Transcriptome-Based Pathways in a Pan-European Systemic Lupus Erythematosus Cohort
  

  Presenting Author: Ioannis Parodis, MD, PhD – Karolinska Institutet
• 5:10 PM – 5:15 PM PT

  Q&A
  
• 5:15 PM – 5:25 PM PT

  High-throughput Proteomics Identities a Spectrum of Novel Serum Biomarkers of Lupus Nephritis
  

  Presenting Author: Huihua Ding, MD – Shanghai Jiao Tong University School of Medicine
• 5:25 PM – 5:30 PM PT

  Q&A